Hua Medicine Limited
The primary objective of this study is to evaluate the long-term safety of Dorzagliatin in a larger population of type 2 diabetes mellitus patients by collecting the post-marketing clinical safety data of Dorzagliatin.
Type2diabetes
Dorzagliatin tablets
PHASE4
This study adopts a multicenter, prospective, and observational cohort study design and does not involve randomization, control, and blinding. Patients with type 2 diabetes mellitus who were prescribed Dorzagliatin according to the package insert and physician's judgment in routine medical practice setting will be included, and the data of these patients during 52-week Dorzagliatin treatment will be collected to evaluate the safety of long-term medication.
Study Type : | INTERVENTIONAL |
Estimated Enrollment : | 2000 participants |
Masking : | NONE |
Primary Purpose : | TREATMENT |
Official Title : | A Multicenter Post-Marketing Observational Study to Evaluate the Long-Term Safety of Dorzagliatin in Patients With Type 2 Diabetes Mellitus |
Actual Study Start Date : | 2023-12-20 |
Estimated Primary Completion Date : | 2026-04-30 |
Estimated Study Completion Date : | 2026-04-30 |
Information not available for Arms and Intervention/treatment
Ages Eligible for Study: | 18 Years |
Sexes Eligible for Study: | ALL |
Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
RECRUITING
China-Japan Friendship Hospital
Beijing, Beijing, China, 100029
RECRUITING
China-Japan Friendship Hospital
Beijing, Beijing, China, 100029